Bovalto Respi 3 contains strains of parainfluenza virus 3, bovine respiratory syncytial virus and Mannheimia haemolytica serotype A1.
Bovalto Respi 4 combines the three pathogens in Bovalto Respi 3, with the addition of bovine viral diarrhoea virus.
According to the company, calf pneumonia costs are around £43/€49* per dairy calf and £82/€93* per suckler calf1.
Boehringer’s vet adviser Ailsa Milnes said: "The majority of these costs are made up of mortality, slower growth rates and reduced lifetime performance.
"It is worth remembering that calf pneumonia can cause irreversible damage to the lungs which means that, even if the animal recovers, its lifetime performance suffers and it will be more susceptible to disease in the future.
"Bovalto Respi 3 and Bovalto Respi 4 are the only vaccines available to demonstrate six months of immunity by challenge for all pathogens, and calves develop protective immunity three weeks after completion of the primary vaccination course.
"Now, with the added flexibility of being able to administer the vaccines to pregnant cattle, the overall level of respiratory disease in a herd will hopefully fall and overall health status improve as a result."
Reference
Protexin says Pro-Kolin Advanced contains beneficial micro-organisms, several prebiotic sources, an optimal level of a dual-source binding agent and soothing fibres to support gastrointestinal function.
The company also says that in a study involving 148 dogs, Pro-Kolin Advanced significantly improved clinical outcome compared to a placebo1.
Protexin Veterinary Director, James Kyffin, said: "Pro-Kolin Advanced represents an exciting development for Protexin Veterinary and fits in perfectly with our ethos to produce innovative, research-based products of the highest quality for pets.
"It is the first product of its kind to be supported by a randomised, controlled clinical trial that was undertaken in first opinion veterinary practices across the UK and Ireland.
"Not only are we pleased to be able to offer veterinary surgeons with an evidence-based option for the management of acute gastrointestinal disturbances, but also a very palatable formulation that was readily accepted by 92% of the dogs in the study."
Pro-Kolin Advanced is available in 15ml, 30ml and 60ml syringes for dogs and 15ml syringes for cats. The flavourings used in the product contain no proteins or common allergens so Pro-Kolin Advanced can be used in animals with known hypersensitivities.
The surgery was carried out in August 2018 and is, they say, the first time it has been performed on a companion animal anywhere in the world. The dog, a five-year old spaniel called Gigha, has now made a full recovery.
Gigha’s surgery was carried out by Dr Guy Killick and featured in a recent episode of The Yorkshire Vet. Guy said: "Gigha provides vital companionship to her owner, Mrs Taylor. She fell into a drainage ditch last summer and this caused a tiny cut on her elbow.
"The initial wound did not seem severe, however, despite intensive decontamination and treatment with broad spectrum antibiotics, the wound proved to have been infected with a resistant Haemolytic E. coli infection, causing a significant loss of skin from the medial aspect of the elbow. During this time, Gigha was hospitalised and was at significant risk of DIC and septicaemia."
"The skin loss was full thickness and, once the compromised tissue was debrided away, she was left with a large wound.
"We managed the wound in hospital for four days with daily dressing changes and an irrigation device to provide local anaesthesia and the delivery of topical antibiotics.
"Unfortunately, skin grafting in her case was not suitable given the infection and a lack of sufficient loose skin to donate. As such, we elected for healing by second intention but, given the large area, we felt it was important to explore novel methods to accelerate the healing process and reduce Gigha’s pain.
"Surgery using Tilapia fish skin grafts was pioneered at UC Davis in the USA and was used successfully on a horse with acid burns in the UK last year. It is still very rare, however, and had not been used to treat an infected wound before. Nor had it been used on a dog.
"Having done our research though and finding that these grafts have a natural anti-infective and analgesic effect, while also reducing the frequency of bandage changes that would cause discomfort and distress to the patient, we felt it was an appropriate treatment for Gigha and carried out the surgery a week after the initial wound."
Guy says the surgery was straightforward and simply involved tacking the skin in place. It adhered to the developing granulation bed, accelerating its growth and providing an antiseptic and analgesic effect. After application, Gigha’s owner reported that she was much brighter and seemed to be in less pain. Pain-scoring during check-ups confirmed this to be the case despite pain relief being voluntarily withdrawn by the owner.
This initial graft stayed in place for two weeks before breaking down and being removed. By this stage, granulation of the wound had been completed and around one cm of neo-epithelisation had occurred. A further graft was then placed which remained for a further two weeks until the wound was 50% of its initial size. No further grafts were placed as the team did not have access to further supplies so they simply bandaged the wound with traditional bandages. It was completely healed within nine weeks. Eight months on, Gigha has made a full recovery and the wound has healed completely.
Guy said: "Given the large wound area and risk of further infection we decided on this novel approach to improve the quality of life for the patient while the wound was healing. While we were naturally apprehensive of making the first attempt at this potentially revolutionary technique, what we knew about fish skin grafts and suggested that they could work in her case so we were determined to give it a try.
"Looking at her now, you wouldn’t believe that she’d been days from death just a few months ago. Her case is a demonstration of the efficacy of fish skin grafts as a treatment for large wounds where there are no other suitable methods of closure – and for their use in dogs. We hope her story and her recovery will be useful to colleagues treating dogs with similar wounds in the future and are happy to discuss the case with them if this would be helpful.
"I would also like to thank Dr Jamie Peyton, Chief of Integrative Medicine Service at UC Davis for her invaluable help and advice during this case and her assistance in the use of the Tilapia graft."
The Disciplinary Committee made its decision last Friday, following an adjournment of the case, which was initially heard in May of this year.
There were three heads of charge against Mr Hough:
The Committee found the majority of the first head of charge not proven, with the exception of the charges that Mr Hough failed to provide and ensure adequate overnight care for Mya and that it was inappropriate and unreasonable for him to plan for the wound management to be undertaken by Mya’s owners following the second procedure on 21 May 2014.
Regarding the second head of charge, the Committee found it proven that Mr Hough did fail to provide information about post-operative care and out-of-hours cover details to Mya’s owners. However it found Mr Hough’s failure to communicate with the owners regarding treatment options and to provide them with adequate information as to Mya’s post-operative condition not proven.
The third head of charge in its entirety was admitted and found proven.
The Committee also found that those charges that were found proven amounted to disgraceful conduct in a professional respect with the exception of Mr Hough’s failure to provide and/or ensure adequate overnight care and his failure to failure to provide out-of-hours details to Mya’s owners.
In deciding on an appropriate sanction, the Committee expressed significant concerns over Mr Hough’s treatment of Mya, in particular his "failure to devise and implement proper and sufficient procedures to ensure that this dog was not released to owners unless it was safe for her to be released and... that the owners were fully advised as to what was required of them."
The Committee felt that Mr Hough had given "insufficient attention" to Mya’s post-operative care but did accept that the conduct represented a single incident. During the course of the hearing the Committee also heard mitigating evidence given on behalf of Mr Hough, with a number of written testimonials as well as witness evidence in support of his clinical expertise and surgical skills.
The Committee accepted that Mr Hough had taken to heart the lessons to be learnt from the charges against him and had implemented a number of written protocols to prevent recurrence of the shortcomings in his treatment of Mya. Furthermore, the Committee also found that Mr Hough had demonstrated insight into the conduct found against him and that he had apologised for the disparaging remarks he made about other veterinary practitioners.
Alistair Barr, chairing the Disciplinary Committee and speaking on its behalf, said: "In short, the Committee is persuaded that Mr Hough has made a good start in putting in place systems to ensure that the interests and welfare of the animals treated at his practice surgeries are not discharged from care until they are fully ready to be discharged and that the owners of such animals will, in future, be fully informed of what might be asked and required of them when their animals are returned into their care after surgery."
He added: "There are no other areas of [Mr Hough’s] professional practices which appear to the Committee to call for improvements. Accordingly, the Committee is persuaded on this evidence that there is reason to believe that the lessons which Mr Hough needed to learn have been learnt and concludes, therefore, that the sanction of a formal and solemn reprimand adequately meets the needs of the public interest in, and requirements of, this particular case. Mya did make a full recovery from her extensive surgery but she and her owners deserved better post-surgery advice and support."
Vetoquinol UK Limited has launched Kefloril, containing 300mg/ml florfenicol for use in cattle and pigs in 100ml and 250ml vials.
In cattle, Kefloril is licensed for preventative and therapeutic treatment of respiratory tract infections. In pigs, Kefloril is licensed for the treatment of acute outbreaks of respiratory disease. Kefloril has the added benefit of traceability stickers which are attached to each vial, designed to make it easier and quicker to record and monitor on-farm usage.
Vetoquinol says the addition of Kefloril to its anti-infective domain provides a cost-effective treatment for respiratory cases this winter.
Concern has been expressed in the profession about environmental contamination from products used in companion animal treatment for ectoparasites, such as fleas and ticks.
In recent years there has been a widely documented fall in the abundance of many terrestrial invertebrate populations1.
While the decline has been mostly linked to agricultural chemicals, there is a concern that companion animal ectoparasiticides could also be a contributing factor, with a recent study2 confirming the presence of common compounds used in flea-treatment3 in UK waterways.
However, the association with companion animal ectoparasiticides is currently poorly understood, with a significant knowledge gap and little robust research available to assess the true importance and environmental consequences.
The funded project ‘Assessing the Environmental Risk from Ectoparasite Treatments in Companion Animals’ will be led by Professor Richard Wall, Professor of Zoology and Dr Emily Bell, Senior Lecturer at University of Bristol in collaboration with Dr Imogen Schofield, Veterinary Statistician and Epidemiologist at CVS, and Lizzie McLennan-Green, Small Animal Veterinary Director at CVS.
It will be conducted via a PhD studentship at the University of Bristol as part of the CVS Clinical Research Awards.
The research will include a longitudinal ‘citizen science’ study with pet owners to develop a greater understanding of owner use and attitudes towards ectoparasiticides.
It will also include laboratory assessments of ectoparasiticide residues collected from companion animals to provide evidence-based information on the potential environmental impact of the treatments when applied to companion animals.
It is hoped the study will help the wider veterinary profession develop the most appropriate approaches to prescribing and use of ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’. The study is also set to benefit companion animals, as the research will inform strategies to ensure the most appropriate control of parasitic burden to pets.
The project starts in January 2023 and will run for three-years as a full time PhD.
CVS is providing £95,000 to fund the research.
References
For the study, which was conducted in 2018 and published this year in Medical and Veterinary Entomology1, practices from around the UK sent in combings from 812 cats and 662 dogs for analysis.
28% of the cats and 14% of the dogs were found to be carrying fleas, with cats from central Wales and the Welsh Borders being more than twice as likely to have fleas than elsewhere in the country. Likewise, dogs from North Wales, the North Wales borders, South Wales and South West England were between 3 and 4.5 times as likely to have fleas as elsewhere.
Of the cats treated with fipronil, 62% (n=57) were still found to be carrying fleas despite treatment. Of the dogs, 44% (n=49) of those treated with fipronil were still carrying fleas. By contrast, 4.1% of cats and 1.4% of dogs treated with fluralaner (Bravecto) were found to have fleas (the lowest of any treatment).
Professor Richard Wall, Veterinary Entomologist at the University of Bristol said: "There is a clear need for greater owner education about the importance of flea treatment and a better understanding of the efficacy of different flea and tick prevention products.
"It is critical for vets to not only recommend the best product for a pet’s needs but to also give a better understanding of the effectiveness and correct application of the different treatments."
Photo: Professor Richard Wall, University of Bristol
Animal Friends is launching a pilot programme through which its customers will be able to check their pets' symptoms, get advice on treatment or find out if they need to visit a vet clinic on Joii.
Paul Hallett, co-founder of Vet-AI said: "Animal Friends is a perfect partner for Vet-AI, not only do we share common goals around animal welfare and the profession as a whole, but strategically we are both laser focused on the customer. In the coming few years we will support their customers by providing them with 24 hour expert-led care, at the click of a button. This will drive our business forward, helping us reach more pet owners and improve the care their pets receive."
Wes Pearson, Managing Director of Animal Friends said: "This partnership demonstrates our commitment to provide our pet parents with innovative options to ensure their pet receives the best care. Being able to access professional advice from the comfort of their own home and at a time that suits them can dramatically reduce stress for both the pet and the pet parent. We are excited to be working with Vet-AI and believe that the Joii app will bring expert knowledge and extra peace of mind to our customers."
Oh no, not another company talking about 'pet parents'. Is it just me, or is it not rather patronising?
In a separate statement, Mr Stevens said: "Anything that gives homeopathy a veneer of credibility risks chancers being able to con more people into parting with their hard-earned cash in return for bogus treatments which at best do nothing, and at worst can be potentially dangerous."
One of the dangers Mr Stevens referred to was the "rise in misinformation about vaccines - some of which is apparently promoted by homeopaths - and which poses a significant danger to human health."
In other words, anyone gullible enough to believe that a dilution of 1,000,000,000,000 parts of water to one part of crude oil, or skimmed milk, or human placenta, or condoms, or anything else for that matter, is going to cure them of anything, is more likely to believe all sorts of anti-vaccine, anti-pharmaceutical company nonsense, something which is very dangerous at a time when vaccination rates have been declining.
Human medicine does not have the monopoly on nonsense, of course. There are those who continue to peddle the lie that homeopathy can cure cancer in animals, and as the declining rates of human vaccination would tend to suggest, no shortage of people prepared to believe them.
Niall Taylor MRCVS, author of No Way To Treat a Friend, said: "The situation in the veterinary profession mirrors that in the medical profession: a small number of people preaching the benefits of a discredited belief system to vulnerable people.
"Some in the profession argue that we should humour those owners who practise homeopathy in animals, as to challenge them would drive them underground. The problem is that if we don't challenge them, we help foster a belief system which doesn't just harm animal health, but human health too. So the skill here is to find ways to challenge these beliefs in a way that is empathetic and constructive."
The latest figures from 2017/18 reveal that over 120 million animals were slaughtered in England and Wales without being stunned first1.
In an open letter to Environment Secretary Michael Gove, the BVA and the RSPCA urge the UK Government to change legislation in England which currently allows non-stun slaughter for religious purposes, and provide further public transparency on this issue by releasing the comprehensive 2018 slaughter survey results, which Mr Gove himself signalled would be published by Autumn 2018.
Until such legislation is in place the RSPCA and BVA are calling for:
meat to be labelled with the method of slaughter, e.g. stunned or non-stunned, so consumers are fully informed about the meat that they are buying.
non-stun slaughter to only be permitted at levels that meet local religious community demand for this type of meat in the interests of limiting animal pain and suffering.
a ban on export of meat from non-stunned animals or live animals destined for non-stun slaughter.
an immediate post-cut stun for cattle, sheep, goats and deer to reduce the period of pain and distress.
The letter follows a recent, high profile decision to ban the slaughter of animals without prior stunning in the Flanders region of Belgium which came into force at the start of the year. Belgium joins several other European countries, including Iceland, Sweden, Switzerland and Denmark in making this decision, demonstrating that a full ban on non-stun slaughter is possible within EU law.
RSPCA chief executive, Chris Sherwood said: "Until there is a change in the law to end non-stun slaughter, there are several measures the UK Government could introduce to reduce the suffering involved in this practice. For example, by ensuring trade deals with other countries do not include non-stun meat or live animals for non-stun slaughter, clear labelling should be adopted to enable consumers to make an informed choice about the meat they buy and how it was slaughtered."
BVA President Simon Doherty said: "The UK Government has repeatedly stated it would prefer to see all animals stunned before slaughter but has taken no action to address this critical welfare issue that affects millions of animals every year. It is doubly disappointing that data that would have provided a valuable benchmark for levels of non-stun slaughter in the UK has yet to see the light of day despite assurances throughout last year that it would soon be made public.
"There is a huge groundswell of support for a ban on non-stun slaughter, and recent developments in Belgium show that decisive change is possible where public support is matched by political will. Michael Gove has made clear that he wants to maintain and build on the UK’s reputation as global leader on animal welfare; banning non-stun slaughter is a surefire way of showing he will deliver on this commitment.
"If slaughter without stunning continues to be permitted in the UK, then meat and fish from this source must be clearly labelled, to help customers make informed choices about the food that they buy and eat."
You can sign the open letter at: www.rspca.org.uk/endnonstun and join the online debate using the hashtag #EndNonStun.
Allegations were reported both in The Times, and the Veterinary Record.
In its statement, the College said: "We know that the University of Edinburgh takes any such accusations extremely seriously and that its inquiry fully and robustly investigated the claims in 2019. This inquiry found no evidence of misconduct, a decision that was later upheld after an appeal.
The College recognised the massive impact that bullying can have on anyone who has been subject to it and acknowledged that the individual accounts published in the Veterinary Record were upsetting to read. However it also drew attention to the 'huge amount of stress that can be caused by ‘trial by media’, especially when an inquiry has concluded that there were no issues to be found'.
As to the role of the RCVS Junior Vice-President, the College pointed out that this is a matter for RCVS Council, as the postholder is elected by Council.
Professor Argyle will be making a statement to Council at its next meeting on 5th November, after which Councillors will be able to ask any questions they have, and then consider the matter.
Meanwhile, the College has asked the Vet Record whether any of the people who made the anonymous testimonials would like to supply any information directly.
The new service, a partnership between the university's School of Veterinary Medicine and Arrogen Forensics, will arm enforcement agencies such as the RSPCA and UK police forces with detailed evidence to help prosecute individuals for crimes against or involving animals.
Arrogen Veterinary Forensics is led by Dr Alex Stoll, Lead Forensic Veterinary Pathologist at the University of Surrey and Operations Director at ArroGen, and Jo Millington, Scientific Director and Lead Forensic Scientist at ArroGen, pictured right.
Alex said: "A key objective is to help investigators increase the success rate in the prosecution of individuals who commit crimes against animals. We are working closely with the RSPCA and UK police forces to optimise the scientific evidence that could form the missing link in their investigations.
"Another objective of the collaboration is to develop a strong social justice agenda with the aim of disrupting crime patterns. It is becoming increasingly well documented that animal cruelty can be used as a component part of domestic violence and there is a growing body of evidence to indicate that people who harm animals are more likely to abuse humans. We want to work with agencies to address the progression of animal to human criminal behaviour."
Jo said: "This unique collaboration brings together experts in animal diagnostics and research with specialists who have worked within the forensic sphere of the UK human Criminal Justice system for many years.
"Why not apply the same principles to the investigation of animal crime? By harnessing our collective knowledge of forensic and animal science we are simply building on our existing infrastructure and experience as human medico-legal practitioners to offer a novel and focussed integrated animal forensics service."
For more information, visit: http://vetforensics.co.uk
IVC says the new brand will allow better communication for equine teams within the IVC Evidensia group as well as collaboration with the wider equine world.
IVC Evidensia Equine Vets range from graduates to European Specialists, working in both dedicated equine and mixed practice, with all practices supported by the four large equine veterinary referral hospitals in the UK: Donnington Grove Veterinary Group, Fyrnwy Equine Group, Oakham Veterinary Hospital and Pool House Equine.
IVC says the brand's mission is to put the welfare of horses at the heart of everything it does, to providing outstanding continuity of care for all equine species and breeds across the network, to be at the forefront of continual professional development, supporting and facilitating the development of clinical and leadership skills across all their equine teams, and to build the leading network for equine veterinary care across Europe.
Richard Stephenson, Chair of the IVC Evidensia Equine Clinical Board, said: "Our network brings together all forms of equine work from ambulatory practice to some of leading UK equine referral centres.
“It gives support to all our staff in their careers. We facilitate clinical development from the graduate academy, through intern training, residencies and training up to European Diplomat level.
“We provide coaching and leadership, flexible roles and friendly, inclusive teams.”
For more information, visit https://www.ivcevidensia.co.uk/Equine or stand B01 at BEVA 2021 congress.
Miss Herdman faced three charges.
The first was that she indicated to a friend that she would supply diazepam and/or tramadol for use by their husband.
The second was that she supplied diazepam and/or tramadol and/or gabapentin.
The third was that she gave advice on the dosages of diazepam and/or tramadol and/or gabapentin.
Miss Herdman was not present at the hearing and was unrepresented, but the Committee determined that it was appropriate to proceed in her absence as she had been notified, was aware that the hearing was taking place and her absence was voluntary.
However, Miss Herdman had been in contact to indicate her pleas to the charges.
She admitted the intention to supply diazepam and/or tramadol and that she had provided advice on the dosages.
She also admitted that she had supplied diazepam but strongly denied that she had supplied tramadol and/or gabapentin.
Taking all the evidence into account (including messages sent by Miss Herdman and her admissions), the Committee found proven the charges in relation to the intent to supply and the advice on dosages.
The Committee also found proven the charge in relation to the supply of diazepam, but found not proved the charge relating to the supply of tramadol and gabapentin for several reasons, including the fact that the messages sent by Miss Herdman did not point unequivocally to her actually suppling each of the drugs to which she referred.
There was no suggestion that the diazepam was stolen from her place of work.
The Committee found that Miss Herdman’s actions had breached paragraphs 1.5 and 6.5 of the Code of Professional Conduct for Veterinary Nurses.
The committee judged that there were a number of aggravating features of Miss Herdman’s conduct, including that she was not qualified or authorised to prescribe medication to animals, let alone to human beings and that providing a controlled drug to a person who was already taking various painkilling medications was reckless.
The Committee also felt that a reasonable and informed member of the public would be very concerned to learn that a veterinary nurse had supplied a controlled drug to a friend for their personal use.
Regarding the sanction for Miss Herdman, Paul Morris, chairing the Veterinary Nursing Disciplinary Committee and speaking on its behalf, said: “Drawing all the material together, and considering the matter as a whole, the Committee had to impose a proportionate sanction for an isolated incident of serious professional misconduct which arose out of a misguided attempt to help a friend.
"The conduct in question was entirely out of keeping with Miss Herdman’s usual practice and there is no real risk that it will be repeated.
"However, this case was much too serious to take no further action and no useful purpose would be served by postponing a sanction.
“The Committee considered that a warning or reprimand would not be sufficient to satisfy the public interest as veterinary nurses are trusted by the public to deal with medication responsibly and failure to do constitutes a severe breach of trust.
“The Committee therefore considered a period of suspension sufficient to meet the public interest in maintaining the reputation of the profession and declaring and upholding proper standards of conduct for members of the profession.
“The Committee also considered whether a removal order would be appropriate but concluded it would be disproportionate and that such a step would remove from the profession an experienced, competent and valuable veterinary nurse for no discernible benefit.
“It was decided that Miss Herdman’s registration be suspended for a period of three months – a period which is sufficient to mark the gravity of the misconduct while taking into account the circumstances in which it arose.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
Andrea Tarr, Veterinary Prescriber’s founder and director said: "Imepitoin is a new licensed option to consider in the management of noise aversion. Our critical look at the available information saves vets time in having find and appraise it themselves, so they can just get on with making the prescribing decision."
Veterinary Prescriber’s reviews are presented as e-learning modules which represent the result of a literature search and collaboration between practising specialists, generalists and the editorial team.
Subscriptions cost £9.95 per month (cancel anytime); practice subscriptions cost £25 per month (for a 12-month contract) and come with free access to cpd.veterinaryprescriber.org, a sister site for vet nurses, receptionists and SQPs.
To subscribe visit: https://www.veterinaryprescriber.org/subscribe
The College says the speed and accuracy of scans produced by the new scanner will revolutionise the treatment of animals at the Queen Mother Hospital for Animals (QMHA). It also reduces the need for animals to be anaesthetised before being scanned, with most patients now only requiring partial sedation.
The new scanner has been named the 'Otter Scanner' after a patient of the RVC whose owner was made a significant donation towards the RVC's charity, the Animal Care Trust, which funded the new machine.
Professor Dan Chan, Professor of Emergency and Critical Care Medicine and Medical Director of the QMHA at the RVC, said: "It is very uncommon that such an incredible leap in the care of animals can be achieved with a single innovation.
"Because of the vast improvement in speed and quality of the images produced by the ‘Otter Scanner’ our specialists are now able to obtain much more detailed images of various diseases affecting our patients so that the best possible treatment can be planned.
"At the RVC, one of our most important missions is to always improve the welfare and care of animals and this latest innovation is just another example of that commitment. We are forever grateful to all our supporters who have made this possible."
This, says the government, would be one of the toughest sanctions in Europe, strengthening the country's claim to be a global leader on animal welfare.
The Animal Welfare (Sentencing) Bill comes after a public consultation held last year which found that more than 70% of people supported proposals for tougher prison sentences. It will allow the courts to take a tougher stance on things like dog fighting, puppy and kitten abuse, and neglect of farm animals.
The new Bill has been welcomed by animal welfare charities.
Chief Executive for the RSPCA, Chris Sherwood, said: "This reform is long overdue. Those responsible for extreme cruelty towards animals or those criminal gangs involved in organised animal crime will now face the tough justice they deserve.
"We need to better protect our animals and the RSPCA hopes that this new Animal Welfare (Sentencing) Bill will give courts the powers they need to punish those responsible for the most unimaginable cruelty to animals.
"We also believe this will act as a much stronger deterrent to others and help us stamp out animal cruelty once and for all."
James Yeates, Cats Protection’s Chief Executive said: "We very much welcome this announcement which is an important step in ensuring the UK is one of the world leaders on animal welfare issues.
Claire Horton, Chief Executive of Battersea Dogs & Cats Home, said: "The introduction of this bill is a landmark achievement, which will make a profound difference to dogs and cats in England and Wales."
According to the survey, 64% of veterinary surgeons now see Brexit as more of a threat than an opportunity for the UK veterinary profession, compared to just half in autumn 2016. Conversely, the number that see Brexit as being more of an opportunity has dropped from 18% to 14% over the same period.
Vets working in academia and industry were the most gloomy: 69% of vets in academia and 58% of vets in industry see Brexit as more of a threat to their own area of work than an opportunity.
The biggest impact appears to have been on veterinary recruitment, with 53% saying Brexit has made it harder to recruit veterinary surgeons, compared to only 18% in 2016. By comparison, only 11% said it has become harder to recruit veterinary nurses.
51% also now consider Brexit as a threat to animal welfare, compared to 43% in 2016.
BVA President Simon Doherty (pictured right, looking decidedly chipper despite it all) said: "As the UK Government ramps up its planning for a no-deal scenario, it’s clear that the veterinary profession is becoming increasingly concerned about the potential impact of Brexit.
"Top of vets’ list of concerns is significant veterinary workforce shortages across critical areas of animal welfare and public health. Veterinary concerns around animal welfare have also increased as the Government continues to stall on introducing new legislation to enshrine animal sentience in UK law before March.
"From pet passports and food safety, to disease surveillance and trade certification, there is no area of veterinary work that is not touched by Brexit. So, we can fully understand why our members are worried about the future. BVA will continue to raise these important veterinary issues with policymakers to ensure the profession is considered as Brexit discussions continue."
The BVA briefings on “Brexit and the veterinary profession” and “No deal Brexit and the veterinary profession” set out all of the issues of interest in more detail.
Budding veterinary impresario Noel Fitzpatrick has announced the dates for the inaugural VET Festival, an outdoor summer event for the profession which will combine world-class CPD with family entertainment and an evening rock concert headlined by Mike Rutherford of Genesis fame.
The VET Festival, sponsored by NVSL and Natural Instinct, will take place in the grounds of the University of Surrey on Saturday 5th and Sunday 6th September 2015.
In a complete departure from the way CPD is usually delivered, lectures will take place in a 1000-seat main theatre marquee in the middle of the university campus, surrounded by smaller breakout tents, exhibitors, family entertainment and 'street food'.
Noel said: "The simple goal of The VET Festival is to provide education which is both cutting-edge and relevant to the day-to-day clinical work of vets, vet nurses and veterinary professionals in companion animal practice. But we also seek to make education fun - like going to a movie - something you can treasure, enjoy and then readily employ in clinical practice.
"There are four lecture strands: orthopaedics, oncology and soft tissue surgery, neurology, and veterinary nursing. Ten education themes will be delivered by world-class lecturers with significant experience in clinical veterinary practice. We will present this education on an innovative platform combining a fun festival atmosphere with dynamic delivery. We aim to provide real value for money, with tickets priced very affordably for a packed educational program which can also form part of the 35 CPD points needed throughout the year."
In addition to Noel himself, speakers at the event (pictured below), include: Will Eward (Assistant Professor of Orthopaedic Surgery Duke University), Nick Bacon (Head of Surgical Oncology, Fitzpatrick Referrals), Julia Tomlinson (Diplomate, American College of Veterinary Sports Medicine and Rehabilitation Twin Cities Animal Rehabilitation and Sports Medicine Clinic), Duncan Lascelles (Professor of Surgery and Pain Management at North Carolina State University College of Veterinary Medicine), Ian G Holsworth (Director VetSurg Small Animal Hospital, Ventura, California), Nick Jeffrey (Professor, Neurology and Neurosurgery College of Veterinary Medicine, Iowa State University), Laurent Findji (Senior Surgeon Soft Tissue and Oncology, Fitzpatrick Referrals) and Jolle Kirpensteijn (Chief Professional Relation Officer, Hill's Pet Nutrition).
And if that wasn't enough, there'll be an evening concert on the Saturday headlined by Mike and the Mechanics. The ONE LIVE concert is being held to promote "One Life One Medicine": the belief that we all only have one life and that there should be a symbiosis of effort to move animal and human medicine forward together. It's in support of The Humanimal Trust, the UK's first charity to further the principles of One Medicine and with the aim of progressing clinically relevant healthcare initiatives for both animals and humans at the same time.
Mike Rutherford said: "I am a huge supporter of 'One Life - One Medicine' - combining animal and human health is an important way forward and I'm looking forward to playing at the Festival, as are the rest of the Mechanics! It will be a fantastic week end - not to be missed!"
As a media partner for the event, VetSurgeon.org will be offering members a special discount, more details to be announced in due course. Publishing Editor Arlo Guthrie said: "Sounds like it should be a lot of fun, and could be a great opportunity for some of our members to meet up and have a pint or two."
All VetSurgeon members can have a 10% discount on the ticket price, by visiting the following link and entering the code VFVSURGEON10
http://www.eventbrite.co.uk/e/the-vet-festival-2015-tickets-16256763417?aff=VFVSURGEON10
For more information about the VET Festival visit: www.vetfestival.co.uk
The Kennel Club has announced the results of a survey of 329 Breed Kennel Rescue organisations which has revealed that over 50% of dogs given up for rehoming are given up by women, compared to 17% by men and 27% by couples who made the decision jointly.
The Kennel Club said the survey also revealed lifestyle changes, a lack of training and time to look after the family pet adequately are the main reasons why dogs are rehomed.
Caroline Kisko, Kennel Club Secretary, said: "People really need to explore their reasons for wanting a dog in the first place, do the research properly and invest time into training their dog. We are seeing an increasing number of owners being driven by celebrity trends in choice of dog breed, such as the French Bulldog, owned by Millie Mackintosh, Jessie J and Jonathan Ross.
"Every year dogs are abandoned or given up when the novelty wears off. Dogs are a lifelong commitment and anyone considering getting a pet needs to be sure that they will be able to properly care for the animal for the rest of its life."
Kennel Club Breed Rescue organisations last year rehomed over 20,000 dogs, more than Dogs Trust and Battersea Dogs & Cats Home combined. January was revealed to be the busiest month, highlighting the impact of many families being unprepared for getting a dog and potentially still buying them as a Christmas gift, despite advice to the contrary. More than one in three breed rescue organisations reported an increase of dogs needing to be rehomed compared with 2012.
Caroline continued: "Although not as well-known as other organisations, Kennel Club Breed Rescues work incredibly hard to support their breed. They are set up and run by people passionate about dogs and their particular breed in particular. There is a breed rescue organisation for almost every one of the 212 breeds of pedigree dog in the UK, and more than one in three of the breed rescue organisations also accept crossbreeds as well as pedigrees.
"Breed rescue is a fantastic place to consider when looking for a dog. The expert staff and volunteers will often know the full history of the dogs in their care and provide you with invaluable knowledge on the breed and tips for caring for individual dogs to make sure the dogs find a family for life."
VetSurgeon is sad to report that Sam Duff, a much loved figure in the profession, died last weekend.
Sam qualified from Edinburgh in 1970, and was a partner in mixed practice in Fife until 2002. More recently, he was a director of Equitique Ltd, an equine reproduction referral practice.
Sam was an active member of BVA Council, and its Member Services Group. He served on SPVS Council from 1993-2002, and was re-elected in 2003. He had recently been elected as Secretary of the Scottish branch of the BVA.
A memorial service will be held at 2.30pm on Thursday 9th July in Younger Hall, St Andrews.
The procedure was performed in Canada through an international collaboration between partners from Germany, Canada and the UK, who say that this was a case where the placement of the tumour made it impossible to operate without severely impacting the dog’s quality of life. The most suitable treatment was a total excision of the growth and reconstruction with an implant.
The implant was designed with medical CAD tools by German company, Voxelmed, using 3D imaging from the affected area. The dog's veterinary surgeon, Julius Liptak, contributed to the design to ensure it met specifications and allowing him to plan the procedure in advance.
UK company Renishaw then additively manufactured the patient specific implant (PSI) at the Additive Design In Surgical Solutions (ADEISS) Centre in London, Ontario, Canada.
Ed Littlewood, Marketing Manager at Renishaw’s Medical and Dental Products Division said: "Without the advancements in additive manufacturing technology, this dog would not have had such a long and happy future ahead of him.
"Prior to this case, many veterinary surgeons were unaware that the technology was available. Similar procedures are now being planned in Germany and further research is underway to see how animals can benefit from additively manufactured PSIs.
Jan Klasen, veterinary surgeon, 3D designer and CEO of Voxelmed said: "Without AM technology, it would have been almost impossible to reconstruct the dog’s maxilla after tumour removal, because the area was extremely complex in geometry. The implant had to have a similar shape and functionality as the dog’s existing bone structure.
"Using additive manufacturing to maintain the original shape and function of the oral and nasal cavity ensures a high quality of life for the dog, just as a naturally shaped skull and maxilla helps the dog to breathe and eat easily."
To read the full case study, visit http://www.renishaw.com/en/additive-manufacturing-in-veterinary-surgery-saving-a-well-loved-member-of-the-family--42950.
The survey, which received 2445 responses from BVA members, found that 16% of vets and vet students have personally experienced discrimination within a veterinary workplace or learning environment in the past twelve months, while 20% had witnessed discrimination.
Senior colleagues were most commonly responsible for the discrimination (47% of incidents), with discrimination from clients accounting for 35% of incidents.
Sex discrimination was the most common type reported (44% of incidents) and was particularly prevalent in academic settings and in production animal, equine, and mixed practices.
Race discrimination was the next most commonly reported (27% of incidents).
Respondents also gave details of discrimination in relation to other protected characteristics, including age, sexuality, disability and gender reassignment.
Younger vets were more likely than older vets to have personally experienced discrimination in the past year (27% of those under 35 had experienced discrimination).
Female vets were more than twice as likely to have experienced discrimination than their male colleagues (19% and 8% respectively).
The incidence of discrimination was higher amongst vets from a range of minority ethnic backgrounds. Those who described their sexual orientation as bi, gay or lesbian were twice as likely to have personally experienced discrimination in the past year.
Despite the high incidence of discrimination reported, responses to the same survey showed that only 56% of the profession feel concerned about discrimination.
British Veterinary Association Junior Vice President Daniella Dos Santos (pictured right) said: "This is the first time anyone has collected such a significant body of evidence on this issue and the results are truly shocking. It is completely unacceptable that so many members of the veterinary team are subject to discrimination not just from clients but from members of our own profession.
"Worryingly, it seems that the scale of the issue will come as a surprise to many members of our profession and so it is vital that we all join the conversation and reflect on what role we can play to improve equality and inclusion. The veterinary team must become a safe and supportive environment for everyone. We cannot accept anything less for ourselves, for our colleagues and for our profession."
Only 12% of respondents were satisfied with how their incident had been dealt, rising to 23% among those who felt able to report. Daniella said: "Many of the experiences documented in our report are shocking and distressing and this distress is often compounded by what comes next. It was very saddening to hear that so many people have felt unable to report their experiences or that their reports were handled badly by those who received them.
"Experiencing discrimination can be very traumatic, without the ‘double-whammy’ of having your complaint dismissed or mishandled by managers or senior staff. We need to make sure everyone who experiences discrimination is able to get the outcome they deserve.
"Through the discrimination questionnaire we heard many distressing stories from vets, students, vet nurses and other colleagues. We are incredibly grateful to them for sharing these with us so that we can raise awareness of what’s happening in our veterinary workplaces."
To raise awareness of the scale of the issue, the BVA is inviting all members of the veterinary team to join a "Big Conversation on equality and inclusion in the veterinary professions", starting with the release of its report on the current situation on discrimination, which can be downloaded here, then inviting everyone to join online engagement sessions through social media and BVA members to feed in views via their regional representatives ahead of Council on 24 July.
The authors say that whilst it has long been suspected that adverse drug reactions are under-reported, this study is the first to show the scale of the problem, using real data from veterinary clinical records.
For the study, researchers looked for electronic heath records within the Small Animal Veterinary Surveillance Network (SAVSNET) which contained “adverse drug reactions” and “side effects” in the free-text clinical narratives.
The results were then analysed to determine the suspected product, the seriousness and expectedness of the event, and whether the event had been reported to the Veterinary Medicines Directorate or Marketing Authorisation Holders.
Of the 827 cases of suspected adverse drug reactions identified out of a total of 10,565 records reviewed, approximately 90% were not reported.
74% were related to dogs and 70% were listed as “expected” (i.e. already listed in the product information).
The clinical severity of the reaction didn’t appear to impact whether it was reported.
Dr Heather Davies, lead author of the study, said: “As adverse drug reaction reporting rate is directly linked to the regulators ability to mitigate safety issues, this paper is a call to arms encouraging all veterinary professionals to report suspected adverse drug reactions and regulators to make reporting quicker and easier.
"It also the highlights the promise that big real-world data sets hold in enhancing drug safety monitoring processes.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13721
The £35 course is aimed at veterinary surgeons, veterinary nurses, receptionists and practice managers who may be faced with difficult and sensitive conversations around pet loss with clients. It covers:
Empathy vs sympathy
Communicating with active listening skills
Open questions
Face-to-face emotional support, telephone support, email support and other written communication
The Blue Cross says that the new course complements its £280, eight-week 'Pet Bereavement Support' course for more in-depth training, and also its hourly webinars, which cost £20.
The eight-week course requires a minimum of three to four hours of study per week and counts towards 32 hours Continual Professional Development.
For specific needs, the Blue Cross can also work with practices to provide bespoke face-to-face training across the UK, specifically tailored and delivered at the practice.
For more information, visit www.bluecross.org.uk/pbss-course or call 01993 867216.